Supernus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extende…

Drug Manufacturers - Specialty & Generic
US, Rockville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Supernus Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Supernus Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Supernus Pharmaceuticals, Inc..

End of SUPN's Analysis
CIK: 1356576 CUSIP: 868459108 ISIN: US8684591089 LEI: - UEI: -
Secondary Listings
SUPN has no secondary listings inside our databases.